24th International AIDS Conference (AIDS 2022)
29 July to 2 August 2022, Montreal, Canada
Simon Collins, HIV i-Base
This year the IAS conference was held in Montreal and also as an impressive fully hybrid conference online.
As usual, the conference had a strong programme that covered all aspects of HIV treatment, prevention, activism and policy. Many specialist workshops were also held in the few days before the main conference.
The programme for the meeting is available online:
This issue of HTB includes the following reports from the conference.
- Dolutegravir no longer linked to higher risk of neural tube defects: latest update from the Tsepamo study
- Weight gain with dolutegravir and TAF in ADVANCE study continues out to week 192
- VRC01 added to early ART in infants no better than early ART alone
- Using PrEP during pregnancy is safe for children
- Long-acting CAB/RPV injections have a similar weight and lipid profile to dolutegravir-based oral ART
- Montreal’s response to monkeypox: rapid vaccine rollout, 39 breakthrough infections
- Summary of 620 cases of monkeypox seen at three London clinics
- Advances in HIV cure-related research: IAS workshop now online